Mar 22, 2023

Starpharma presents at ASX Small and Mid-Cap Conference (ASX Announcement)

Starpharma presents at ASX Small and Mid-Cap Conference (ASX Announcement)

 

Melbourne, Australia; 22 March 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) announces that Starpharma CEO Dr Jackie Fairley will present a brief overview of the Company at the ASX Small and Mid-Cap Conference today at 11:00am AEDT. The Conference showcases selected ASX-listed companies to Australian investors.

Starpharma’s presentation will include a brief overview of its portfolio, key value drivers and outlook, including:

  • the Company’s clinical-stage DEP® programs;
  • multiple DEP® partnerships with global companies;
  • new AZD0466 data, including preclinical data in small cell lung cancer (SCLC) and clinical data in Phase 1 solid-tumour patients, which will be presented by AstraZeneca at the upcoming American Association for Cancer Research Annual Meeting in April 2023; and
  • on-market products including VIRALEZE™ and VivaGel®

Investors are invited to join the Conference by registering online at:  https://www2.asx.com.au/
investors/investment-tools-and-resources/events/smid

The presentation can be viewed here. 

 This contains certain forward-looking statements.